The reality of Trump's drug prices will be set in the next 18 months
NovartisThe CEO warned Tuesday that U.S. drug pricing policy under President Donald Trump poses a “very difficult situation” and that…
Roche Holding AG
AstraZeneca shares rise after surprise lung disease trial win
AstraZenecaShares rose more than 3% after Britain's most valuable company said its experimental drug for lung diseases met its target…
Abivax Stock Rises to Become Top Biotech Acquisition Target
Europe's best-performing blue-chip stocks in 2025 are expected to be bought by a larger peer, in a deal analysts say…
Nine pharmaceutical companies sign agreements with Trump to lower drug prices
US President Donald Trump speaks during an event in the Roosevelt Room of the White House on December 19, 2025…
Zealand Pharma unveils 2030 plan as weight loss competition heats up
Celsopupo | Stock | fake images Zealand Pharma outlined an ambitious five-year strategy for its anti-obesity portfolio on Thursday, highlighting…
Eli Lilly's Obesity Drug Amylin Shows Up to 20% Weight Loss in Study
The Eli Lilly Biotechnology Center is shown in San Diego, California, on March 1, 2023. Mike Blake | Reuters Eli…
Genentech Launches Direct-to-Consumer Program for Flu Pill Xofluza
A sign stands in front of a Genentech office on June 12, 2025 in south San Francisco, California. Justin Sullivan…
Trump The threat of the pharmaceutical rate decreases after the Pfizer agreement
The president of the United States, Donald Trump, shakes hand with the Pfizer CEO, Albert Bourla (L), while announcing an…
Roche plans to become the best obesity player as CT-388 enters trial
The Roche Holding AG headquarters on April 11, 2025, in Basel, Switzerland. Sedat Suna | Getty Images News | Getty…
How LPG-1s, Wogovy, Zepbound are restructuring the economy
Eternalcreative | Istock | Getty images Miraculous drugs, obesity treatments and skinny blows. They call them what they want, few…